Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|September 20, 2022
A Simple, Fast, and Reliable LC-MS/MS Method for the Measurement of Homovanillic Acid and Vanillylmandelic Acid in Urine SpecimensVrajesh Pandya, Elizabeth L Frank
Journal of Analytical Toxicology|June 16, 2022
Can Umbilical Cord and Meconium Results Be Directly Compared? Analytical Approach MattersVrajesh Pandya, Chase Wilker, Gwendolyn A McMillin
Journal of Analytical Toxicology|April 20, 2023
Longitudinal trends in meconium drug detection in 46 US states between the years 2015 and 2020Vrajesh Pandya, Chase Wilker, Kamisha L Johnson-Davis
The Journal of Applied Laboratory Medicine|November 14, 2022
Deceptively Simple: Can Urine Samples from CLIA-Waived Urine Drug Screen Devices Be Reused for Confirmatory Testing?Vrajesh Pandya, Gwendolyn A McMillin, Brittany A Young
Frontiers in Nephrology|November 6, 2024
Desidustat: a novel PHD inhibitor for the treatment of CKD-induced anemiaAmit Joharapurkar, Vrajesh Pandya, Harilal Patel, et al.
Clinical Biochemistry|November 10, 2022
Spirited away: Can ethanol testing in add-on orders provide meaningful results?Vrajesh Pandya, Anh H T Nguyen Sorenson, Erin Jones, et al.
Journal of Analytical Toxicology|January 13, 2025
Beyond the baseline: quantification of two phosphatidylethanol homologues in whole blood by LC-MS-MS and retrospective data analysis from a National Reference LaboratoryNicole J Mathewson, Nkemakonam C Okoye, Heather A Nelson, et al.
Oncotarget|April 28, 2016
The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancerVrajesh Pandya, Darryl Glubrecht, Larissa Vos, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 26, 2022
Nonclinical Pharmacokinetic Evaluation of Desidustat: a Novel Prolyl Hydroxylase Inhibitor for the Treatment of AnemiaHarilal Patel, Nirav Modi, Jaimin Chaudhari, et al.
Cell Death & Disease|June 13, 2020
BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancerVrajesh Pandya, John Maringa Githaka, Namrata Patel, et al.
Pageof 2